Gadolinium-based contrast agents (GBCA) are commonly used to identify blood-brain-barrier disruption. Recent studies reported gadolinium deposition in deep gray matter (GM) structures, following serial injections of linear complexes of GBCA. While it is recognized that linear complexes of GBCA may lead to gadolinium retention in brain, macrocyclic GBCA should also be evaluated. In this study, we investigated the effect of serial macrocyclic GBCA injections in 92 Multiple Sclerosis patients followed during seven years. Our results did not show any significant signal intensity changes in deep GM structures, and particularly in the dentate nuclei and the globus pallidus.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords